The pharmaceutical sector stocks in India showed positive movement on March 18, 2026, during early trading hours, with many scrips recording gains on both BSE and NSE.

The S&P BSE HEALTHCARE Index stood at 42,746.0, up 0.6% at the time of the update (around 09:23-09:24 AM IST). This compared to the broader market, where the S&P BSE SENSEX was at 76,461.21 (up 0.51%) and NIFTY 50 was at 23,676.15 (up 0.40%).

Within the pharmaceuticals sector, several stocks posted gains, while a few saw declines or mixed performance across exchanges. Key examples from the provided data include:

  • Gufic Bioscience: Up 3.94% on BSE to ₹294.10.
  • Dishman Carbogen Amcis: Up 3.33% on BSE to ₹169.00.
  • Alembic: Up 2.87% on BSE to ₹81.72.
  • Gland Pharma: Up 2.69% on NSE to ₹1,699.10 (higher gain on NSE).
  • Panacea Biotec: Up 2.84% on BSE to ₹326.45.
  • Solara Active Pharma Sciences: Up 2.20% on BSE to ₹438.85.
  • Syngene International: Up 1.88% on BSE to ₹418.35.
  • Supriya Lifescience: Up 1.76% on NSE to ₹590.85.
  • Ajanta Pharma: Up 1.59% on BSE to ₹3,069.00.
  • Aster DM Healthcare: Up 1.54% on BSE to ₹679.95.

Major large-cap names showed modest gains:

  • Sun Pharma: Up 0.32% on BSE to ₹1,801.40.
  • Dr. Reddy’s Lab: Up 0.35% on BSE to ₹1,287.60.
  • Cipla: Up 0.07% on BSE to ₹1,282.30.
  • Divis Laboratories: Up 0.58% on BSE to ₹6,120.00.
  • Alkem Laboratories: Up 0.36% on BSE to ₹5,353.45.

Some stocks traded lower:

  • Ipca Labs: Down 1.03% on BSE to ₹1,551.15.
  • Jubilant Industries: Down 4.08% on BSE to ₹1,639.05.
  • Wyeth: Mixed, with significant variance noted (down 2.27% on BSE but outlier data on NSE).

Top gainers in the broader pharmaceuticals space (as noted) included Source Natural Foods (up 8.6%) and Guj.Terc Lab (up 7.7%), while losers featured Parmax Pharma (down 11.7%) and Trimurthi Drugs (down 6.8%).

The sector’s performance aligned with broader market positivity on the day, though recent analyses indicate mixed outlook for 2026, with challenges in the first half due to factors like generic competition and regulatory pressures, and potential recovery later. The S&P BSE HEALTHCARE Index was down 0.5% over the last 30 days but up 7.6% over the last year.

Also Read: IT sector rally today, March 18: TCS jumps 2.40%, Wipro surge 2.30%, HCL Tech up 2.14, Infosys rises 1.65%

Add us as preferred source on Google
TOPICS: Pharma sector